Linganisha mbinu

	CushQoL: Dodoso la Ubora wa Maisha wa Ugonjwa wa Cushing	AGHDA: Tathmini ya Upungufu wa Homoni ya Ukuaji kwa Watu Wazima
Nyanja	Endokrinolojia	Endokrinolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2008	2000
Mwanzilishi	Sergio Webb, María D. Bernal, Juan M. Rivera-Caravaca	Anthony Hunt, Garry Werther, Peter Wrightson
Aina	Patient self-report questionnaire	Patient self-report questionnaire
Chanzo asilia	Webb, S. M., Bernal, M. D., Rivera-Caravaca, J. M., & Córdoba-Soriano, J. G. (2008). Development and validation of CushQoL, a disease-specific quality of life questionnaire in Cushing's syndrome. J Clin Endocrinol Metab, 93(5), 1751-1759.	Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346.
Majina mbadala	Cushing QoL, CS-QoL	AGHDA-25
Zinazohusiana	3	3
Muhtasari	CushQoL is a disease-specific 12-item quality of life questionnaire developed to assess the multidimensional impacts of Cushing's syndrome—a severe endocrine disorder characterized by excess cortisol production. Developed by Webb and colleagues in 2008, it captures physical symptoms (fatigue, weight gain, weakness, hirsutism), psychological manifestations (depression, anxiety, cognitive impairment), and social/occupational dysfunction unique to Cushing's syndrome. It is the standard outcome measure for assessing quality of life improvement following curative therapy.	The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy.